The investigators have now cloned the cDNA encoding a homeobox transcription factor related to Drosophila NK2. As the seventh vertebrae factor in this family, the new factor is tentatively designated PCF/Nkx2.7. Nkx 2.1 to 2.6 are all developmental regulators of organogenesis, and studies are proposed to determine the role of PCF/Nkx 2.7 in liver development and neoplasia.
Aim 1 studies will focus on the new gene: the transcriptional regulatory controls will be characterized, and in addition, a closely related gene will be cloned and sequenced.
In Aim 2, the properties of the PCF/Nkx 2.7 molecule will be analyzed by deletion of peptide domains and GAL4 gene fusion. Subsequently, the binding partners will be determined using direct assays and the yeast two-hybrid system.
Aim 3 evaluates the role of PCF/Nk 2.7 in development through analysis of embryos and cell cultures. A mouse inducible gene targeting model will be used to confine gene knock-out to the foregut, the embryonic region that gives rise to the liver, or to the early embryo. Finally, Aim 4 deals with cancer -related aspects. A rearranged PCF/Nkx 2.7 has been found in a human hepatocarcinoma cell line, suggested a possible role in cell transformation. This putative translocation will be sequenced and mapped. Studies will evaluate PCF/Nkx 2.7 as a transforming gene in cell lines, and in primary culture of hepatocytes. Together these Aims represent a comprehensive approach to this new gene, based on the model that abnormal reactivation of PCF/Nkx 2.7 recapitulates developmental controls to transform liver cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA076354-03
Application #
6190940
Study Section
Special Emphasis Panel (ZRG2-ET-1 (05))
Program Officer
Mietz, Judy
Project Start
1998-07-01
Project End
2003-04-30
Budget Start
1999-11-16
Budget End
2000-04-30
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Pathology
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Locker, Joseph; Segall, Jeffrey E (2011) Breast cancer: the matrix is the message. Am J Pathol 178:966-8
Harris, Thomas; Pan, Qiulu; Sironi, Juan et al. (2011) Both gene amplification and allelic loss occur at 14q13.3 in lung cancer. Clin Cancer Res 17:690-9
Kajiyama, Yasuo; Tian, Jianmin; Locker, Joseph (2006) Characterization of distant enhancers and promoters in the albumin-alpha-fetoprotein locus during active and silenced expression. J Biol Chem 281:30122-31
Tian, Jianmin; Mahmood, Radma; Hnasko, Robert et al. (2006) Loss of Nkx2.8 deregulates progenitor cells in the large airways and leads to dysplasia. Cancer Res 66:10399-407
Pirity, Melinda K; Locker, Joseph; Schreiber-Agus, Nicole (2005) Rybp/DEDAF is required for early postimplantation and for central nervous system development. Mol Cell Biol 25:7193-202
Columbano, Amedeo; Ledda-Columbano, Giovanna M; Pibiri, Monica et al. (2005) Gadd45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia. Hepatology 42:1118-26
Locker, Joseph; Tian, Jianmin; Carver, Robert et al. (2003) A common set of immediate-early response genes in liver regeneration and hyperplasia. Hepatology 38:314-25
Kajiyama, Yasuo; Tian, Jianmin; Locker, Joseph (2002) Regulation of alpha-fetoprotein expression by Nkx2.8. Mol Cell Biol 22:6122-30
Locker, Joseph; Ghosh, David; Luc, Phuong-Van et al. (2002) Definition and prediction of the full range of transcription factor binding sites--the hepatocyte nuclear factor 1 dimeric site. Nucleic Acids Res 30:3809-17
Vorachek, W R; Steppan, C M; Lima, M et al. (2000) Distant enhancers stimulate the albumin promoter through complex proximal binding sites. J Biol Chem 275:29031-41